A phase II trial that was stopped because of unexpected deaths, and then restarted in July this year, has been suspended again following the death of more patients. The trial of an experimental chimeric antigen receptor T-Cell (CAR-T) therapy JCAR015 by Juno Therapeutics involved adult patients with relapsed or refractory B cell acute lymphoblastic leukaemia. ...
Leukaemia drug trial stopped for second time
29 Nov 2016